TnMUC1
Phase 1- Indications
- Lung cancer, Pancreatic cancer, Triple-negative breast cancer, Ovarian cancer
Company intelligence / Profile preview
Tmunity Therapeutics
Philadelphia/East Norriton, Pennsylvania, USAkitepharma.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Phase 1
01
Overview
Tmunity Therapeutics was a private clinical-stage biotherapeutics company focused on developing next-generation engineered T-cell immunotherapies—primarily CAR-T—for the treatment of various cancers. The company had multiple programs in clinical development targeting both solid and hematologic malignancies. Its proprietary ‘armored’ CAR-T platform aimed to enhance anti-tumor activity. In early 2023, it was acquired by Kite Pharma/Gilead Sciences to complement their existing cell therapy pipeline. Some assets were excluded from the deal.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapies (Chimeric Antigen Receptor T cells)Engineered T cell receptors (TCRs)Regulatory T cells
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
University of Pennsylvania – foundational collaboration/licensing agreementParker Institute for Cancer ImmunotherapyUniversity of California San FranciscoChildren’s Hospital of Philadelphia
Beyond the preview
Go deeper on Tmunity Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tmunity Therapeutics.